ATE129411T1 - Natriumhyaluronat-zusammensetzung. - Google Patents

Natriumhyaluronat-zusammensetzung.

Info

Publication number: ATE129411T1
Authority: AT; Austria
Prior art keywords: sodium hyaluronate; hyaluronate composition; hyaluronate; composition; opthalamological
Prior art date: 1988-05-16

Application number

AT90104673T

Other languages

English (en)

Inventor

David A Swann

Bernard P Sullivan

Dale P Devore

Original Assignee

Medchem Products Inc

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1988-05-16

Filing date

1990-03-12

Publication date

1995-11-15

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=25674005&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ATE129411(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

1990-03-12 Application filed by Medchem Products Inc filed Critical Medchem Products Inc

1995-11-15 Application granted granted Critical

1995-11-15 Publication of ATE129411T1 publication Critical patent/ATE129411T1/de

Links

229920002385 Sodium hyaluronate Polymers 0.000 title abstract 2
229940010747 sodium hyaluronate Drugs 0.000 title abstract 2
YWIVKILSMZOHHF-QJZPQSOGSA-N sodium;(2s,3s,4s,5r,6r)-6-[(2s,3r,4r,5s,6r)-3-acetamido-2-[(2s,3s,4r,5r,6r)-6-[(2r,3r,4r,5s,6r)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2- Chemical compound [Na+].CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 YWIVKILSMZOHHF-QJZPQSOGSA-N 0.000 title abstract 2
WCDDVEOXEIYWFB-VXORFPGASA-N (2s,3s,4r,5r,6r)-3-[(2s,3r,5s,6r)-3-acetamido-5-hydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-4,5,6-trihydroxyoxane-2-carboxylic acid Chemical compound CC(=O)N[C@@H]1C[C@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](C(O)=O)O[C@@H](O)[C@H](O)[C@H]1O WCDDVEOXEIYWFB-VXORFPGASA-N 0.000 abstract 1
230000000694 effects Effects 0.000 abstract 1
229940014041 hyaluronate Drugs 0.000 abstract 1
230000004410 intraocular pressure Effects 0.000 abstract 1
239000002504 physiological saline solution Substances 0.000 abstract 1
230000002980 postoperative effect Effects 0.000 abstract 1
239000000243 solution Substances 0.000 abstract 1
238000001356 surgical procedure Methods 0.000 abstract 1

Classifications

- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
- C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
- C08B37/006—Heteroglycans, i.e. polysaccharides having more than one sugar residue in the main chain in either alternating or less regular sequence; Gellans; Succinoglycans; Arabinogalactans; Tragacanth or gum tragacanth or traganth from Astragalus; Gum Karaya from Sterculia urens; Gum Ghatti from Anogeissus latifolia; Derivatives thereof
- C08B37/0063—Glycosaminoglycans or mucopolysaccharides, e.g. keratan sulfate; Derivatives thereof, e.g. fucoidan
- C08B37/0072—Hyaluronic acid, i.e. HA or hyaluronan; Derivatives thereof, e.g. crosslinked hyaluronic acid (hylan) or hyaluronates
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0048—Eye, e.g. artificial tears
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L31/00—Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
- A61L31/04—Macromolecular materials
- A61L31/042—Polysaccharides
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/06—Antiglaucoma agents or miotics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/12—Ophthalmic agents for cataracts
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2430/00—Materials or treatment for tissue regeneration
- A61L2430/16—Materials or treatment for tissue regeneration for reconstruction of eye parts, e.g. intraocular lens, cornea

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Ophthalmology & Optometry (AREA)
Animal Behavior & Ethology (AREA)
Medicinal Chemistry (AREA)
Veterinary Medicine (AREA)
Organic Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Chemical Kinetics & Catalysis (AREA)
Engineering & Computer Science (AREA)
Epidemiology (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Bioinformatics & Cheminformatics (AREA)
Heart & Thoracic Surgery (AREA)
Surgery (AREA)
Vascular Medicine (AREA)
Molecular Biology (AREA)
Biochemistry (AREA)
Materials Engineering (AREA)
Polymers & Plastics (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Polysaccharides And Polysaccharide Derivatives (AREA)
Medicinal Preparation (AREA)

AT90104673T 1988-05-16 1990-03-12 Natriumhyaluronat-zusammensetzung. ATE129411T1 (de)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US07/194,187 US4920104A (en)	1988-05-16	1988-05-16	Sodium hyaluronate composition
CA002011956A CA2011956C (en)	1988-05-16	1990-03-12	Sodium hyaluronate composition

Publications (1)

Publication Number	Publication Date
ATE129411T1 true ATE129411T1 (de)	1995-11-15

Family

ID=25674005

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AT90104673T ATE129411T1 (de)	1988-05-16	1990-03-12	Natriumhyaluronat-zusammensetzung.

Country Status (6)

Country	Link
US (1)	US4920104A (de)
EP (1)	EP0399156B1 (de)
JP (1)	JP3065327B2 (de)
AT (1)	ATE129411T1 (de)
CA (1)	CA2011956C (de)
DE (1)	DE69023163T2 (de)

Families Citing this family (31)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
EP0589871B1 (de) *	1990-02-13	2000-04-26	Ethicon, Inc.	Peritoneal wirksame medikamente
IT1247175B (it) *	1991-04-19	1994-12-12	Fidia Spa	Procedimento per la purificazione di acido ialuronico e frazione di acido ialuronico puro per uso oftalmico.
US5234914A (en) *	1991-06-11	1993-08-10	Patent Biopharmaceutics, Inc.	Methods of treating hemorrhoids and anorecial disease
IT1254712B (it) *	1992-01-20	1995-10-09		Uso dell'acido ialuronico lubrificante di protesi oculari.
US5612027A (en) *	1995-04-18	1997-03-18	Galin; Miles A.	Controlled release of miotic and mydriatic drugs in the anterior chamber
IT1277707B1 (it) *	1995-12-22	1997-11-11	Chemedica Sa	Formulazione oftalmica a base di ialuronato di sodio per uso nella chirurgia oculare
US6541460B2 (en)	1996-08-07	2003-04-01	George D. Petito	Method for use of hyaluronic acid in wound management
EP1027065A1 (de) *	1997-02-13	2000-08-16	Bausch & Lomb Surgical, Inc.	Methode zur zerstörung von retinalen pigmentepithelzellen
SE9700827D0 (sv) *	1997-03-07	1997-03-07	Pharmacia & Upjohn Ab	Ophthalmic composition
US6368585B1 (en)	1997-03-25	2002-04-09	Pharmacia Ab	Opthalmic compositions and methods
US6638917B1 (en)	2000-02-25	2003-10-28	Scimed Life Systems, Inc.	Reducing adhesion
US20040101561A1 (en) *	2002-11-13	2004-05-27	Jafari Masoud R.	Combinations of viscoelastics for use during surgery
US7820194B2 (en) *	2001-12-21	2010-10-26	Alcon, Inc.	Combinations of viscoelastics for use during surgery
EP1507543A4 (de) *	2002-05-09	2006-07-26	Cambridgemed Inc	Pharmazeutische zusammensetzung zur behandlung von wunden mit blutplasma oder serum
RU2005102604A (ru) *	2002-07-03	2005-09-10	Перикор Сайенс, Инк. (Us)	Композиция гиалуроновой кислоты и способы применения
US20040167480A1 (en) *	2003-02-21	2004-08-26	Advanced Medical Optics, Inc.	Administration of multiple viscoelastic solutions with a multi-compartment syringe
US20050101582A1 (en)	2003-11-12	2005-05-12	Allergan, Inc.	Compositions and methods for treating a posterior segment of an eye
US20060141049A1 (en) *	2003-11-12	2006-06-29	Allergan, Inc.	Triamcinolone compositions for intravitreal administration to treat ocular conditions
US20070224278A1 (en) *	2003-11-12	2007-09-27	Lyons Robert T	Low immunogenicity corticosteroid compositions
DE602005011928D1 (de)	2004-01-20	2009-02-05	Allergan Inc	Zusammensetzungen für die lokalisierte therapie des auges, vorzugsweise enthaltend triamcinolon-acetonid und hyaluronsäure
US8119154B2 (en)	2004-04-30	2012-02-21	Allergan, Inc.	Sustained release intraocular implants and related methods
US8147865B2 (en)	2004-04-30	2012-04-03	Allergan, Inc.	Steroid-containing sustained release intraocular implants and related methods
WO2006017347A2 (en) *	2004-07-12	2006-02-16	Allergan, Inc.	Opthalmic compositions and methods for treating ophthalmic conditions
WO2006043965A1 (en) *	2004-10-14	2006-04-27	Allergan, Inc.	Therapeutic ophthalmic compositions containing retinal friendly excipients and related methods
US20060159651A1 (en) *	2005-01-14	2006-07-20	Michael Colvard	Gradient molecular weight viscoelastic solutions
US7323184B2 (en) *	2005-08-22	2008-01-29	Healagenics, Inc.	Compositions and methods for the treatment of wounds and the reduction of scar formation
US8668676B2 (en) *	2006-06-19	2014-03-11	Allergan, Inc.	Apparatus and methods for implanting particulate ocular implants
US9039761B2 (en)	2006-08-04	2015-05-26	Allergan, Inc.	Ocular implant delivery assemblies with distal caps
US8545554B2 (en) *	2009-01-16	2013-10-01	Allergan, Inc.	Intraocular injector
WO2011057275A2 (en) *	2009-11-09	2011-05-12	Arizona Board of Regents, a body corporate acting for and on behalf of Arizona State University	Molecular films for hydrophobic implant surfaces
IT1402382B1 (it) *	2010-09-09	2013-09-04	Ibsa Inst Biochimique Sa	Complessi cooperativi ibridi di acido ialuronico

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4141973A (en) *	1975-10-17	1979-02-27	Biotrics, Inc.	Ultrapure hyaluronic acid and the use thereof
US4328803B1 (en) *	1980-10-20	1994-01-11	Opthalmic Systems, Inc.	Opthalmological procedures
SE442820B (sv) *	1984-06-08	1986-02-03	Pharmacia Ab	Gel av tverbunden hyaluronsyra for anvendning som glaskroppssubstitut
US4713375A (en) *	1985-08-01	1987-12-15	Lindstrom Richard L	Viscoelastic solution

1988
- 1988-05-16 US US07/194,187 patent/US4920104A/en not_active Expired - Lifetime
1990
- 1990-03-12 CA CA002011956A patent/CA2011956C/en not_active Expired - Lifetime
- 1990-03-12 AT AT90104673T patent/ATE129411T1/de not_active IP Right Cessation
- 1990-03-12 DE DE69023163T patent/DE69023163T2/de not_active Expired - Lifetime
- 1990-03-12 EP EP90104673A patent/EP0399156B1/de not_active Expired - Lifetime
- 1990-03-16 JP JP02064472A patent/JP3065327B2/ja not_active Ceased

Also Published As

Publication number	Publication date
EP0399156A1 (de)	1990-11-28
DE69023163D1 (de)	1995-11-30
CA2011956C (en)	1998-02-03
US4920104A (en)	1990-04-24
DE69023163T2 (de)	1996-06-27
JP3065327B2 (ja)	2000-07-17
EP0399156B1 (de)	1995-10-25
CA2011956A1 (en)	1991-09-12
JPH03271228A (ja)	1991-12-03

Legal Events

Date	Code	Title
1996-07-15	UEP	Publication of translation of european patent specification
1997-09-15	EEIH	Change in the person of patent owner
2001-12-15	REN	Ceased due to non-payment of the annual fee

Publication	Publication Date	Title
DE69023163D1 (de)	1995-11-30	Natriumhyaluronat-Zusammensetzung.
ATE233083T1 (de)	2003-03-15	Synthetisches viskoseelastisches material für physiologische anwendungen wie für ophtalmologische anwendungen
AU5841090A (en)	1991-01-08	Sulphated polysaccharides, anticoagulant agent and anticomplementary agent obtained from brown algae fucuses and method of obtaining same
DK0418339T3 (da)	1995-04-03	Præparat og fremgangsmåde til forebyggelse af sammenvoksninger mellem kropsvæv
EP1154287A3 (de)	2002-02-13	Sauerstoffdurchlässige Kontaktlinse mit hydrophiler Oberfläche und Verfahren zur Herstellung derselben
IE881150L (en)	1988-10-16	Low molecular weight heparins of regular structure, their¹preparation and their biological uses
ES2148504T3 (es)	2000-10-16	Acido hialuronico sulfatado en el que el numero de grupos sulfato por unidad repetitiva varia entre 0,5 y menos de 2.
IT1277707B1 (it)	1997-11-11	Formulazione oftalmica a base di ialuronato di sodio per uso nella chirurgia oculare
BR0016336A (pt)	2002-08-27	Combinações de substâncias ativas fungicidas
KR890004720A (ko)	1989-05-09	성장 인자를 함유하는 겔 제형
KR890011918A (ko)	1989-08-23	개선된 의료용 폴리(프로필렌 글리콜 푸마레이트)조성물
NO180668C (no)	1997-05-28	Kryss-bundede, sårsekretabsorberende hydrogeler
BR0215149A (pt)	2004-10-19	Uso de nanopartìculas inorgânicas para modificar a viscosidade e outras propriedades fìsicas de composições farmacêuticas e óticas
BR9915235A (pt)	2001-07-24	ácidos hialurÈnicos reticulados e usos médicos dos mesmos
ATE309693T1 (de)	2005-07-15	Zusammensetzungen enthaltend heparin mit niedrigem molekülargewicht
NZ333925A (en)	2000-07-28	Use of heparin or heparan sulphate in combination with chitosan for the prevention or treatment of infections caused by herpes virus
BR9708502A (pt)	1999-07-03	Fluido de estocagem corneal compreendido por ácido hialurônico
ES8800605A1 (es)	1987-11-16	Procedimiento para preparar una composicion coloeada de utilidad en cirugia ocular.
ATE115741T1 (de)	1994-12-15	Multifokallinse.
EP1564230A3 (de)	2009-12-09	Polyacrylamid-Hydrogel und seine Verwendung als Endoprothese
CA2282757A1 (en)	1998-09-11	Opthalmic composition
MX9701609A (es)	1998-04-30	Composicion espesada por un alquileter de polisacarido.
ATE325828T1 (de)	2006-06-15	Polymerträger mit polyoxalkylenen
FI934902A0 (fi)	1993-11-05	Genetisk kontroll av acetylening och puryvylening av xantan baserade polysackaridpolymerer
KR880001290A (ko)	1988-04-22	β-차단제 및 필로카르핀-함유 제제